AiDAPT (automated insulin delivery amongst pregnant women with type 1 diabetes) is a multicenter randomized controlled trial, currently still in progress, whose aim is to evaluate the impact of AHCL during pregnancy in women with type 1 diabetes. Here, INS is linked to type 1 diabetes mellitus.